Rxcurve
HCPCS J9261 · per 50 MG

Nelarabine injection

Products billed under this code include Arranon, Nelarabine.

Payment limit per 50 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J9261

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Arranon Sandoz Inc. 00078-0683-61 5 $204.36
Arranon Sandoz Inc. 66758-0165-94 5 $204.36
Nelarabine Sagent Pharmaceuticals 25021-0259-50 5 $204.36
Nelarabine Sagent Pharmaceuticals 25021-0259-51 30 $1,226.16
Nelarabine XGen Pharmaceuticals DJB, Inc. 39822-0650-01 5 $204.36
Nelarabine XGen Pharmaceuticals DJB, Inc. 39822-0650-06 30 $1,226.16
Nelarabine Dr. Reddy's Laboratories Inc. 43598-0142-06 30 $1,226.16
Nelarabine Dr. Reddy's Laboratories Inc. 43598-0142-11 5 $204.36
Nelarabine Alembic Pharmaceuticals Inc. 62332-0813-50 5 $204.36
Nelarabine Amneal Pharmaceuticals, LLC 70121-1743-04 30 $1,226.16
Show all 20 products
ProductLabelerNDCUnits / pkgLimit / pkg
Nelarabine Zydus Pharmaceuticals (USA) Inc. 70710-1726-01 5 $204.36
Nelarabine Zydus Pharmaceuticals (USA) Inc. 70710-1726-08 30 $1,226.16
Nelarabine Zydus Pharmaceuticals (USA) Inc. 70710-1839-01 5 $204.36
Nelarabine Zydus Pharmaceuticals (USA) Inc. 70710-1839-08 30 $1,226.16
Nelarabine Meitheal Pharmaceuticals Inc. 71288-0165-53 30 $1,226.16
Nelarabine Meitheal Pharmaceuticals Inc. 71288-0165-54 5 $204.36
Nelarabine Novadoz Pharmaceuticals LLC 72205-0154-01 5 $204.36
Nelarabine Novadoz Pharmaceuticals LLC 72205-0154-04 30 $1,226.16
Nelarabine Shorla Oncology Inc. 81927-0111-01 5 $204.36
Nelarabine Shorla Oncology Inc. 81927-0111-06 30 $1,226.16

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $40.872 −$24.535 50 MG Nelarabine injection v1, posted September 17, 2026
3Q26 $65.407 +$12.70 50 MG Nelarabine injection v1, posted September 15, 2026
2Q26 $52.707 −$12.453 50 MG Nelarabine injection v1, posted September 15, 2026
1Q26 $65.16 −$14.702 50 MG Nelarabine injection v1, posted September 15, 2026
4Q25 $79.862 +$16.483 50 MG Nelarabine injection v1, posted September 8, 2026
3Q25 $63.379 +$0.195 50 MG Nelarabine injection v1, posted March 10, 2026
2Q25 $63.184 −$11.571 50 MG Nelarabine injection v1, posted March 10, 2026
1Q25 $74.755 +$2.228 50 MG Nelarabine injection v1, posted December 19, 2025
4Q24 $72.527 −$0.793 50 MG Nelarabine injection v1, posted June 11, 2025
3Q24 $73.32 −$28.605 50 MG Nelarabine injection v1, posted June 11, 2025
2Q24 $101.925 −$9.057 50 MG Nelarabine injection v1, posted March 11, 2025
1Q24 $110.982 −$5.665 50 MG Nelarabine injection v1, posted December 19, 2024
4Q23 $116.647 −$12.347 50 MG Nelarabine injection v1, posted October 10, 2024
3Q23 $128.994 −$0.841 50 MG Nelarabine injection v1, posted June 5, 2024
2Q23 $129.835 −$5.448 50 MG Nelarabine injection v1, posted February 23, 2024
1Q23 $135.283 +$7.892 50 MG Nelarabine injection v1, posted December 6, 2023
4Q22 $127.391 −$2.749 50 MG Nelarabine injection v1, posted June 22, 2023
3Q22 $130.14 −$6.795 50 MG Nelarabine injection v1, posted June 9, 2023
2Q22 $136.935 −$18.962 50 MG Nelarabine injection v1, posted December 14, 2022
1Q22 $155.897 $0.00 50 MG Nelarabine injection v1, posted June 8, 2022
4Q21 $155.897 +$3.456 50 MG Nelarabine injection v1, posted June 2, 2022
3Q21 $152.441 +$0.544 50 MG Nelarabine injection v1, posted June 2, 2022
2Q21 $151.897 +$0.009 50 MG Nelarabine injection v1, posted March 1, 2022
1Q21 $151.888 – 50 MG Nelarabine injection v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files